Podcast: The Power of Partnership: Bridging Patients and Payers in Duchenne Muscular Dystrophy Management
Listen to the episode here!
Learning Objectives
At the completion of this activity, participants should be able to:
1. Discuss managed care considerations to incorporate the patient value and access to innovative therapies into managed care decision-making for improved health outcomes in Duchenne Muscular Dystrophy.
Commercial Support
This activity is supported by an independent medical education grant from ITF Therapeutics.
Faculty:
Steven Kheloussi, PharmD, MBA, FAMCP
Principal Consultant
Kheloussi Consulting, LLC
Moderator:
Fred Goldstein
Financial Relationship Disclosures:
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Fred Goldstein Moderator | Disclosed no relevant financial relationships. |
| Steven Kheloussi Faculty | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN: 0233-0000-25-077-H01-P
Activity Type: Knowledge-Based
Contact Hours: 0.25
Release Date: December 4, 2025
Expiration Date: December 31, 2026
Activity Fee: Free for Members and Non-Members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher).
- Complete a specific activity evaluation.
Available Credit
- 0.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward